House Of Reps OK For Health Insurance Bill

14 April 1996

Finally, the US House of Representatives has approved legislation to guarantee portability of health insurance for those who lose or leave their jobs (Marketletter April 1). The bill, the first major effort to expand health insurance coverage to reach the floor since President Clinton's ill-fated 1994 ambitious health plan, limits to 12 months the length of time an insurer could deny coverage based on pre-existing medical conditions and would let those who lost group insurance buy individual policies.

The measure now goes back to the Senate, where Majority Leader Bob Dole has scheduled a debate for this month on a more modest measure which has bipartisan backing as well as the support of the White House.

Other provisions in the House bill include ceilings on medical malpractice and medical savings accounts, which have been criticized by the White House and Democrats. An attempt to substitute a more limited measure failed, as did a try to replace it with the Senate version.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight